Sign In
Buy DRIO
$6.81
+0.0441 (+0.651%)
At Close: Jul 17, 2026
DarioHealth Appoints Two New Board Members
01:30pm, Thursday, 05'th Mar 2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the company has appointed Yadin Shemmer and Adam K. Stern to serve as board members effective imm
Those Who Purchased DarioHealth (NASDAQ:DRIO) Shares Five Years Ago Have A 90% Loss To Show For It
01:04pm, Wednesday, 04'th Mar 2020
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. We don't wish...
DarioHealth Digital Diabetes Management System is Now Available at Albertsons
01:00pm, Monday, 24'th Feb 2020
DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes an
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or "Dario"), a pioneer in the global digital therapeutics market, today presented a new clinical study at the Advanced Technologies & Treatments for Dia
DarioHealth Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10:30pm, Friday, 31'st Jan 2020
DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced today that on January 30, 2020, Richard Anderson was granted a non-qua
Israeli digital therapeutics company raises $21.3M for U.S. expansion
09:32pm, Friday, 20'th Dec 2019
Publicly-traded DarioHealth plans to use the cash to put its smartphone-based glucometer into the hands of insurers.
